9:38 ET -- GSK PLC and Sanofi SA are among the most talked about companies in the U.S. across all news items in the last 12 hours, according to Factiva data. A U.S. judge dismissed a series of lawsuits, numbering in the tens of thousands, around the Zantac heartburn treatment that both GSK and Sanofi had marketed. The judge in a multidistrict ruling concluded there was no scientific evidence to support the claim Zantac's active ingredient was carcinogenic. The decision could be appealed. U.S.-traded shares of GSK and Sanofi opened roughly 0.9% and 1.8% lower, respectively. Dow Jones & Co. owns Factiva. (robb.stewart@wsj.com)

 

(END) Dow Jones Newswires

December 07, 2022 09:53 ET (14:53 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Historical Stock Chart
From Jan 2023 to Feb 2023 Click Here for more GSK Charts.
GSK (NYSE:GSK)
Historical Stock Chart
From Feb 2022 to Feb 2023 Click Here for more GSK Charts.